Intrathecal colistin for drug-resistant Acinetobacter baumannii central nervous system infection: a case series and systematic review
Open Access
- 1 July 2010
- journal article
- case report
- Published by Elsevier BV in Clinical Microbiology & Infection
- Vol. 16 (7), 888-894
- https://doi.org/10.1111/j.1469-0691.2009.03019.x
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Antimicrobial Resistance:Acinetobacter baumannii:Epidemiology, Antimicrobial Resistance, and Treatment OptionsClinical Infectious Diseases, 2008
- Multidrug-resistant Acinetobacter meningitis in neurosurgical patients with intraventricular catheters: assessment of different treatmentsJournal of Antimicrobial Chemotherapy, 2008
- Treatment Options for??Multidrug-Resistant Acinetobacter SpeciesDrugs, 2008
- Cure of multiresistant Acinetobacter baumannii central nervous system infections with intraventricular or intrathecal colistin: case series and literature reviewJournal of Antimicrobial Chemotherapy, 2006
- Tigecycline: First of a New Class of Antimicrobial AgentsPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2006
- Treatment of multidrug resistant AcinetobacterCurrent Opinion in Infectious Diseases, 2005
- Use of colistin in the treatment of multiple-drug-resistant gram-negative infectionsAmerican Journal of Health-System Pharmacy, 2005
- Multidrug-ResistantAcinetobacter baumanniiEmerging Infectious Diseases, 2005
- PHARMACOKINETICS AND PHARMACODYNAMICS OF ANTIBIOTICS IN MENINGITISInfectious Disease Clinics of North America, 1999
- Adverse Effects of Sodium ColistimethateAnnals of Internal Medicine, 1970